tradethefifthcompany

HALO - Potential 5th ElliottWave Swing Trading Opportunity

Long
NASDAQ:HALO   Halozyme Therapeutics, Inc.
Using our Elliott Wave Indicator Suite for the TradingView Platform we have identified a potential Long 5th Wave Swing Trading Opportunity for HALO on the Daily time frame . The 5th wave move in an elliottwave sequence is the highest probability move. The large impulse moves, waves 1 and 3, were obvious news events with large volume. The volume on the wave 4 pull back has stared to run out of juice, which is a good sign.

The wave 4 pull back has found support in the Red zone of our probability pullback zones, which represents an 75% probability that our automated 5th wave target zone, in blue on the chart, will be hit. Further more the profit taking pull back is at major support and resistance zone from previous range period.

We see yellow dots formed in the overbought zone on our special False Breakout Stochastic indicator, which signals strong Bullish momentum. When, during a wave 4 pullback, the stochastic pulls back against these false break out dots and crosses in the oversold zone, there is a high probability the stocks price action will resume the overall bullish trend .

We also measure the wave 4 behaviour with our Elliottwave oscillator, which has pulled back within our pre-determined zone.

So overall we have identified, using our Elliott Wave Indicator suite for TradingView, a high probability long swing trading opportunity for HALO , Weekly Time Frame , with the following entry strategy:

We use our 6/4 MA High for initial starting point for long entries and take into consideration and recent pivots during the 4th wave pullback.

Long entry through $18.63
Stop Loss $17.63
Target $20.20
Giving a Risk to Reward of 1:1.7
Comment:
Adjust Stop for order to $17.50 - Still leaves a great RR to our automated 5th wave target zone

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.